Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100004YC3
Xinxiang Tuoxin Pharmaceutical Co.Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 421.69 m CNY | 378.34 m CNY |
| Gross profit | 125.95 m CNY | 99.80 m CNY |
| Operating income | -13.91 m CNY | -47.65 m CNY |
| EBIT | -27.68 m CNY | -72.23 m CNY |
| Net income | -19.88 m CNY | -69.66 m CNY |
| Diluted EPS – continuing operations | -0.16 CNY | -0.55 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Xinxiang Tuoxin Pharmaceutical Co.Ltd.
Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. The company was founded in 2001 and is based in Xinxiang, China.
More stocks
- Zenitron Corp (3028.TW)
- Newtechwood Corp (301588.SZ)
- Taiwan Paiho Ltd (9938.TW)
- Homag Group (HG1.F)
- Dazhong Transportation Group Co Ltd B (900903.SS)
- Industrial Logistics Properties Trust (ILPT)
- DukSan Neolux Co.Ltd (213420.KQ)
- Ningbo Color Master Batch Co. Ltd. (301019.SZ)
- Suzhou Future Electrical Company Co. Ltd. A (301386.SZ)
- Hunan Resun Co Ltd (001218.SZ)
- Fine Semitech Corp (036810.KQ)
- NORWOOD FINANCIAL CORP (NWFL)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.